Microtubule-associated protein tau in human prostate cancer cells: Isoforms, phosphorylation, and interactions

Journal of Cellular Biochemistry

Volumn 108, Issue 3, 2009, Pages 555-564

  Souter, Skye ^a   Lee, Gloria ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Microtubule binding; Phosphatidylinositol 3 kinase; Phosphorylation; Prostate cancer cells; Tau

Indexed keywords

ISOPROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; TAU PROTEIN;

ADULT; ARTICLE; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; CELL LINE, TUMOR; CYTOSKELETON; HUMANS; MALE; MICROTUBULES; MOLECULAR SEQUENCE DATA; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROSTATIC NEOPLASMS; PROTEIN BINDING; PROTEIN ISOFORMS; PROTEIN TRANSPORT; TAU PROTEINS;

EID: 70350180734     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22287     Document Type: Article

References (50)

1. Andreadis A. 2005. Tau gene alternative splicing: Expression patterns, regulation and modulation of function in normal brain and neurodegenerative diseases. Biochim Biophys Acta 1739:91-103. (Pubitemid 40018532)
2. Andreadis A, Brown WM, Kosik KS. 1992. Structure and novel exons of the human tau gene. Biochemistry 31:10626-10633.
3. Ashman JB, Hall ES, Eveleth J, Boekelheide K. 1992. Tau, the neuronal heatstable microtubule-associated protein, is also present in the cross-linked microtubule network of the testicular spermatid manchette. Biol Reprod 46:120-129.
4. Augustinack JC, Schneider A, Mandelkow EM, Hyman BT. 2002. Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease. Acta Neuropathol 103:26-35. (Pubitemid 36075309)
5. Biernat J, Gustke N, Drewes G, Mandelkow EM, Mandelkow E. 1993. Phosphorylation of Ser262 strongly reduces binding of tau to microtubules: Distinction between PHF-like immunoreactivity and microtubule binding. Neuron 11:153-163. (Pubitemid 23222542)
6. Binder LI, Frankfurter A, Rebhun LI. 1985. The distribution of tau in the mammalian central nervous system. J Cell Biol 101:1371-1378. (Pubitemid 16203754)
7. Botez G, Probst A, Ipsen S, Tolnay M. 1999. Astrocytes expressing hyperphosphorylated tau protein without glial fibrillary tangles in argyrophilic grain disease. Acta Neuropathol 98:251-256. (Pubitemid 29396856)
8. Couchie D, Mavilia C, Georgieff IS, Liem RK, Shelanski ML, Nunez J. 1992. Primary structure of high molecular weight tau present in the peripheral nervous system. Proc Natl Acad Sci USA 89:4378-4381.
9. Cross DC, Munoz JP, Hernandez P, Maccioni RB. 2000. Nuclear and cytoplasmic tau proteins from human nonneuronal cells share common structural and functional features with brain tau. J Cell Biochem 78:305-317. (Pubitemid 30415906)
10. Feinstein SC, Wilson L. 2005. Inability of tau to properly regulate neuronal microtubule dynamics: A loss-of-function mechanism by which tau might mediate neuronal cell death. Biochim Biophys Acta 1739:268-279. (Pubitemid 40018544)
11. Garcia-Sierra F, Ghoshal N, Quinn B, Berry RW, Binder LI. 2003. Conformational changes and truncation of tau protein during tangle evolution in Alzheimer's disease. J Alzheimers Dis 5:65-77. (Pubitemid 36582767)
12. Ghoshal N, Garcia-Sierra F, Wuu J, Leurgans S, Bennett DA, Berry RW, Binder LI. 2002. Tau conformational changes correspond to impairments of episodic memory in mild cognitive impairment and Alzheimer's disease. Exp Neurol 177:475-493. (Pubitemid 35366136)
13. Goedert M, Spillantini MG, Crowther RA. 1992. Cloning of a big tau microtubule-associated protein characteristic of the peripheral nervous system. Proc Natl Acad Sci USA 89:1983-1987.
14. Greenberg SG, Davies P, Schein JD, Binder LI. 1992. Hydrofluoric acid-treated tau PHF proteins display the same biochemical properties as normal tau. J Biol Chem 267:564-569.
15. Gu Y, Oyama F, Ihara Y. 1996. Tau is widely expressed in rat tissues. J Neurochem 67:1235-1244. (Pubitemid 26277937)
16. Hernandez F, Avila J. 2007. Tauopathies. Cell Mol Life Sci 64:2219-2233.
17. Husseman JW, Nochlin D, Vincent I. 2000. Mitotic activation: A convergent mechanism for a cohort of neurodegenerative diseases. Neurobiol Aging 21:815-828.
18. Jimeno A, Hallur G, Chan A, Zhang X, Cusatis G, Chan F, Shah P, Chen R, Hamel E, Garrett-Mayer E, Khan S, Hidalgo M. 2007. Development of two novel benzoylphenylurea sulfur analogues and evidence that the microtubule- associated protein tau is predictive of their activity in pancreatic cancer. Mol Cancer Ther 6:1509-1516. (Pubitemid 46954017)
19. Johnson GV, Stoothoff WH. 2004. Tau phosphorylation in neuronal cell function and dysfunction. J Cell Sci 117:5721-5729. (Pubitemid 40123939)
20. Kim H, Strong TV, Anderson SJ. 1991. Evidence for tau expression in cells of monocyte lineage and its in vitro phosphorylation by v-fms kinase. Oncogene 6:1085-1087. (Pubitemid 21924191)
21. Kohnken R, Buerger K, Zinkowski R, Miller C, Kerkman D, DeBernardis J, Shen J, Moller HJ, Davies P, Hampel H. 2000. Detection of tau phosphorylated at threonine 231 in cerebrospinal fluid of Alzheimer's disease patients. Neurosci Lett 287:187-190. (Pubitemid 30339380)
22. Lee G, Rook SL. 1992. Expression of tau protein in non-neuronal cells: Microtubule binding and stabilization. J Cell Sci 102(Pt 2):227-237.
23. Lee G, Newman ST, Gard DL, Band H, Panchamoorthy G. 1998. Tau interacts with src-family non-receptor tyrosine kinases. J Cell Sci 111(Pt 21):3167-3177. (Pubitemid 28532427)
24. Lee G, Thangavel R, Sharma VM, Litersky JM, Bhaskar K, Fang SM, Do LH, Andreadis A, Van Hoesen G, Ksiezak-Reding H. 2004. Phosphorylation of tau by fyn: Implications for Alzheimer's disease. J Neurosci 24:2304-2312. (Pubitemid 38314562)
25. LoPresti P, Szuchet S, Papasozomenos SC, Zinkowski RP, Binder LI. 1995. Functional implications for the microtubule-associated protein tau: Localization in oligodendrocytes. Proc Natl Acad Sci USA 92:10369-10373.
26. Luo MH, Leski ML, Andreadis A. 2004. Tau isoforms which contain the domain encoded by exon 6 and their role in neurite elongation. J Cell Biochem 91:880-895.
27. Mercken M, Vandermeeren M, Lubke U, Six J, Boons J, Van de Voorde A, Martin JJ, Gheuens J. 1992. Monoclonal antibodies with selective specificity for Alzheimer Tau are directed against phosphatase-sensitive epitopes. Acta Neuropathol 84:265-272.
28. Mimori K, Sadanaga N, Yoshikawa Y, Ishikawa K, Hashimoto M, Tanaka F, Sasaki A, Inoue H, Sugimachi K, Mori M. 2006. Reduced tau expression in gastric cancer can identify candidates for successful Paclitaxel treatment. Br J Cancer 94:1894-1897. (Pubitemid 43882581)
29. Mirabella M, Alvarez RB, Bilak M, Engel WK, Askanas V. 1996. Difference in expression of phosphorylated tau epitopes between sporadic inclusion-body myositis and hereditary inclusion-body myopathies. J Neuropathol Exp Neurol 55:774-786. (Pubitemid 26238580)
30. Mukrasch MD, von Bergen M, Biernat J, Fischer D, Griesinger C, Mandelkow E, Zweckstetter M. 2007. The "jaws" of the tau-microtubule interaction. J Biol Chem 282:12230-12239.
31. Nagao SI, Kumamoto T, Masuda T, Ueyama H, Toyoshima I, Tsuda T. 1999. Tau expression in denervated rat muscles. Muscle Nerve 22:61-70. (Pubitemid 28564038)
32. Otvos L, Jr., Feiner L, Lang E, Szendrei GI, Goedert M, Lee VM. 1994. Monoclonal antibody PHF-1 recognizes tau protein phosphorylated at serine residues 396 and 404. J Neurosci Res 39:669-673.
33. Preuss U, Doring F, Illenberger S, Mandelkow EM. 1995. Cell cycle-dependent phosphorylation and microtubule binding of tau protein stably transfected into Chinese hamster ovary cells. Mol Biol Cell 6:1397-1410.
34. Reynolds CH, Garwood CJ, Wray S, Price C, Kellie S, Perera T, Zvelebil M, Yang A, Sheppard PW, Varndell IM, Hanger DP, Anderton BH. 2008. Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases. J Biol Chem 283:18177-18186.
35. Rokhlin OW, Bishop GA, Hostager BS, Waldschmidt TJ, Sidorenko SP, Pavloff N, Kiefer MC, Umansky SR, Glover RA, Cohen MB. 1997. Fasmediated apoptosis in human prostatic carcinoma cell lines. Cancer Res 57:1758-1768. (Pubitemid 27199671)
36. Rouzier R, Rajan R, Wagner P, Hess KR, Gold DL, Stec J, Ayers M, Ross JS, Zhang P, Buchholz TA, Kuerer H, Green M, Arun B, Hortobagyi GN, Symmans WF, Pusztai L. 2005. Microtubule-associated protein tau: A marker of paclitaxel sensitivity in breast cancer. Proc Natl Acad Sci USA 102:8315-8320. (Pubitemid 40800086)
37. Sangrajrang S, Denoulet P, Millot G, Tatoud R, Podgorniak MP, Tew KD, Calvo F, Fellous A. 1998. Estramustine resistance correlates with tau overexpression in human prostatic carcinoma cells. Int J Cancer 77:626-631. (Pubitemid 28340913)
38. Sarkar M, Kuret J, Lee G. 2008. Two motifs within the tau microtubule-binding domain mediate its association with the hsc70 molecular chaperone. J Neurosci Res 86:2763-2773.
39. Seubert P, Mawal-Dewan M, Barbour R, Jakes R, Goedert M, Johnson GV, Litersky JM, Schenk D, Lieberburg I, Trojanowski JQ, Lee VM. 1995. Detection of phosphorylated Ser262 in fetal tau, adult tau, and paired helical filament tau. J Biol Chem 270: 18917-18922.
40. Smith CJ, Anderton BH, Davis DR, Gallo JM. 1995. Tau isoform expression and phosphorylation state during differentiation of cultured neuronal cells. FEBS Lett 375:243-248.
41. Thurston VC, Zinkowski RP, Binder LI. 1996. Tau as a nucleolar protein in human nonneural cells in vitro and in vivo. Chromosoma 105:20-30.
42. Vallee RB. 1986a. Purification of brain microtubules and microtubule-associated protein 1 using taxol. Methods Enzymol 134:104-115.
43. Vallee RB. 1986b. Reversible assembly purification of microtubules without assembly-promoting agents and further purification of tubulin, microtubule-associated proteins, and MAP fragments. Methods Enzymol 134:89-104.
44. Vanier MT, Neuville P, Michalik L, Launay JF. 1998. Expression of specific tau exons in normal and tumoral pancreatic acinar cells. J Cell Sci 111(Pt 10):1419-1432. (Pubitemid 28274393)
45. Vogelsberg-Ragaglia V, Bruce J, Richter-Landsberg C, Zhang B, Hong M, Trojanowski JQ, Lee VM. 2000. Distinct FTDP-17 missense mutations in tau produce tau aggregates and other pathological phenotypes in transfected CHO cells. Mol Biol Cell 11:4093-4104.
46. Wagner P, Wang B, Clark E, Lee H, Rouzier R, Pusztai L. 2005. Microtubule associated protein (MAP)-tau: A novel mediator of paclitaxel sensitivity in vitro and in vivo. Cell Cycle 4:1149-1152. (Pubitemid 41365380)
47. Wang J, Tse SW, Andreadis A. 2007. Tau exon 6 is regulated by an intricate interplay of trans factors and cis elements, including multiple branch points. J Neurochem 100:437-445. (Pubitemid 46011004)
48. Wei ML, Andreadis A. 1998. Splicing of a regulated exon reveals additional complexity in the axonal microtubule-associated protein tau. J Neurochem 70:1346-1356. (Pubitemid 28136946)
49. Weingarten MD, Lockwood AH, Hwo SY, Kirschner MW. 1975. A protein factor essential for microtubule assembly. Proc Natl Acad Sci USA 72:1858-1862.
50. Yang Y, Herrup K. 2007. Cell division in the CNS: Protective response or lethal event in post-mitotic neurons? Biochim Biophys Acta 1772:457-466.